Predicting Myriad Diseases From a Single Drop of Blood
By Dennis Thompson HealthDay Reporter
TUESDAY, July 23, 2024 -- A single drop of blood might be able to predict the onset of dozens of diseases, a new study claims.
Analysis of the protein “signatures” in a droplet of blood can predict 67 diseases, including blood cancers, degenerative nerve diseases, lung disease and heart failure, researchers reported July 22 in the journal Nature Medicine.
For the study, researchers analyzed the blood proteins of more than 40,000 randomly selected participants in the ongoing UK Biobank study.
Looking at the participants’ electronic health records, researchers pinpointed 5 to 20 proteins most closely associated with each disease.
These protein “signatures” outperformed other standard tests that used measures like blood cell counts, cholesterol levels, kidney function and blood sugar levels to predict the 67 diseases, researchers report.
“Several of our protein signatures performed similar or even better than proteins already trialled for their potential as screening tests, such as prostate specific antigen for prostate cancer,” said lead researcher Julia Carrasco Zanini Sanchez, a postdoctoral researcher with the Precision Healthcare University Research Institute at Queen Mary University of London.
“We are therefore extremely excited about the opportunities that our protein signatures may have for earlier detection and ultimately improved prognosis for many diseases,” Sanchez added in a university news release.
Such a simple blood test could not only improve early detection of diseases, but might also help in the search for new medicines, said senior researcher Robert Scott, vice president and head of human genetics and genomics at the pharmaceutical company GSK.
“A key challenge in drug development is the identification of patients most likely to benefit from new medicines,” Scott said.
Protein blood tests could be used “to identify individuals at high risk across a wide range of diseases, and aligns with our approach to use tech to deepen our understanding of human biology and disease,” Scott added.
However, the researchers said their findings need to be validated in different groups of people, including folks from different ethnic groups and with varying levels of symptoms for different diseases.
Sources
- Queen Mary University of London, news release, July 22, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
Gun Deaths to Children and Teens Have Risen in Almost All States
FRIDAY, Sept. 6, 2024 -- As news of yet another senseless school shooting makes headlines, a new report finds the number of children who lose their lives to injury and gun...
Cuffs on At-Home Blood Pressure Monitors Don't Fit Some Patients
FRIDAY, Sept. 6, 2024 -- People are encouraged to monitor their blood pressure at home, but many folks will find that household blood-pressure cuffs are literally a bad fit, a new...
Seeing Through: Scientists Use Food Dye to Render Mouse Skin Transparent
FRIDAY, Sept. 6, 2024 -- It seems like a kind of superpower, but scientists say they've used a common food dye to render the skin of a mouse transparent, revealing the workings of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.